Clinical Trial Update: The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether adding human menopausal gonadotropin after oocyte retrieval improves outcomes in IVF cycles.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Human menopausal gonadotropin (human menopausal gonadotropin)

Snippet

Sponsor: Cairo University | Conditions: Infertility | Phase 4 | Status: COMPLETED